ArticleFood science & nutrition2026
Correlation Between Dietary Index for Gut Microbiota With All-Cause and Cardiovascular Mortality in Cardiovascular-Kidney-Metabolic Syndrome Patients.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The link between the dietary index for gut microbiota (DI-GM) and the risk of death in the Cardiovascular-Kidney-Metabolic Syndrome (CKM) population remains unclear. Our research investigates the relationship between DI-GM and mortality in CKM patients. Data from 13,562 individuals diagnosed with CKM, obtained from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2018, were analyzed. Kaplan-Meier curves, Cox regression, smooth curve fitting, and Subgroup analyses were applied to assess the link between DI-GM and mortality. During the average 82-months follow-up period, a total of 1236 deaths occurred, including 371 cases of cardiovascular death. Kaplan-Meier analysis showed that the lowest DI-GM group exhibited the highest rates of mortality. Multivariable Cox regression found that a one-point increase in the DI-GM score was associated with a 10% reduction in all-cause mortality risk and a 12% decrease in cardiovascular mortality risk. Smooth curve fitting and continuous dose-response estimates indicated a negative linear relationship between DI-GM scores and both all-cause and cardiovascular mortality, consistent across various subgroups. This research reveals that higher DI-GM concentrations in CKM syndrome patients correlate strongly with improved survival outcomes, especially for all-cause mortality and cardiovascular death among patients in CKM stages 0-3, while also showing significant benefits for all-cause mortality among patients in CKM stage 4.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.